Literature DB >> 2149402

Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemia.

S Karfa1, R Gopal, J S Nadkarni.   

Abstract

This study examines the immunophenotypic profiles in both pretreated and treated CLL patients which could be useful from the prognosis point of view. Patients suffering from B CLL and having IgG markers were relatively more aggressive than cells bearing IgM phenotypes. Male predominance is observed in male/female ratio in this disease. B CLL showed heterogeneity by showing reactivity against various T cell markers such as CD5 (present on mature T cells) and also CD4 (T helper/inducer), CD8 (T suppressor/cytotoxic) and a very high percentage of Ia (HLA-DR). The proliferative response to cells to stimulation with PHA and PWM indicated that there is a primary defect in the capacity of these small lymphocytes to undergo a proliferative response due to an intrinsic defect in the B lymphocytes. This study also reflects a maturation arrest in the later developmental stage of B lymphopoiesis. The three findings which are novel are the difference in prognosis between IgG-IgM and IgG, the changes in T cell subsets and the mitogenic response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149402     DOI: 10.1007/bf02987105

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  27 in total

1.  Suppressor T cells in B-cell chronic lymphocytic leukaemia: relationship to clinical stage.

Authors:  K H Mills; J C Cawley
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

2.  Lymphocyte response to pokeweed mitogen in chronic lymphocytic leukemia.

Authors:  H V Lamberson; F R Davey; C M Schreck; K Zamkoff; A S Kurec
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

3.  Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia.

Authors:  E Matutes; A Wechsler; R Gomez; M Cherchi; D Catovsky
Journal:  Br J Haematol       Date:  1981-12       Impact factor: 6.998

Review 4.  Molecular aspects of immunoglobulin expression by human B cell leukemias and lymphomas.

Authors:  J Gordon
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

5.  Tumor cell killing by freshly isolated peripheral blood monocytes.

Authors:  D G Fischer; W J Hubbard; H S Koren
Journal:  Cell Immunol       Date:  1981-03-01       Impact factor: 4.868

6.  Chronic lymphocytic leukemia: a monoclonal disease.

Authors:  D L Solanki; P R McCurdy; R P MacDermott
Journal:  Am J Hematol       Date:  1982-09       Impact factor: 10.047

Review 7.  A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky
Journal:  Blood Cells       Date:  1987

8.  Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia.

Authors:  H M Grey; E Rabellino; B Pirofsky
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

9.  Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.

Authors:  F Caligaris-Cappio; M Gobbi; M Bofill; G Janossy
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  The monoclonality of human B-cell lymphomas.

Authors:  R Levy; R Warnke; R F Dorfman; J Haimovich
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.